Please provide your email address to receive an email when new articles are posted on . NATIONAL HARBOR, Md. — Among PROVE-HF trial participants with HF with reduced ejection fraction and moderate to ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter mitral valve repair improved outcomes and symptoms in patients with moderate to severe mitral ...

LONDON -- Despite another positive trial, controversy rages on over transcatheter edge-to-edge repair (TEER or M-TEER) in people with symptomatic heart failure (HF) and functional mitral regurgitation ...

Ischemic mitral regurgitation of moderate severity develops in approximately 10% of patients after myocardial infarction. 1,2 Mitral regurgitation is caused by the displacement of papillary muscle, ...

Cleft mitral valve is a congenital lesion that is usually associated with endocardial cushion defects such as a primum atrial septal defect. Rarely (as in this case) is a cleft mitral valve present as ...

Among patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite guideline-directed medical therapy, transcatheter edge-to-edge repair ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--egnite, Inc., a leading cardiovascular digital health company, announced today that novel research on mitral regurgitation (MR) was presented by cardiologist ...

While previous trials have led to questions surrounding the potential benefits of valve interventions in mitral or tricuspid regurgitation, a pair of trials presented recently demonstrate their ...

Some dopamine agonists (pergolide [Permax] or cabergoline [Dostinex]) used to treat Parkinson’s disease may be associated with cardiac-valve regurgitation, based on a case-control study (N Engl J Med.

PARIS — By assessing residual regurgitation after a transcatheter tricuspid valve repair with a four-grade rather than three-grade system, physicians can predict survival more accurately, reported ...